Echinocandin B Market - Global Forecast 2026-2032

The Echinocandin B market is undergoing considerable transformation, shaped by heightened expectations around supply resilience, quality assurance, and global sourcing strategies. Senior decision-makers operating in this space are examining new approaches to procurement and risk management to ensure sustained access to this indispensable antifungal intermediate.

Market Snapshot: Echinocandin B Market Size and Trajectory

The Echinocandin B market expanded from USD 267.82 million in 2025 to USD 305.95 million in 2026, with projections indicating it will reach USD 612.34 million by 2032. This compound annual growth rate of 12.54% results from sustained demand for antifungal innovation, regulatory advancement, and the increasing integration of fermentation-derived active pharmaceutical ingredients across global value chains. Pharmaceutical manufacturers and biopharma procurement leaders are responding to these shifts by seeking partners who can support scalable, high-compliance sourcing that withstands the operational and regulatory demands unique to this specialty ingredient.

Scope & Segmentation: Diverse Applications and Strategic Suppliers

Product Forms & Grades: Segmented by use-case, Echinocandin B is sourced for research, preclinical, and regulated applications, each defined by specific documentation and varying levels of purity to fulfill both development and manufacturing requirements.
Applications: Utilized as a starting or intermediate material for downstream semisynthetic echinocandin development, as well as serving for reference standards, comparators, and analytical method validation.
End-Users: Procurement approaches differ by segment, including pharmaceutical manufacturers focused on compliance, biotechnology firms prioritizing innovation, CDMOs/CMOs emphasizing turnaround, and academic research entities seeking flexibility.
Procurement Models: Sourcing strategies now include direct supplier relations for traceability, distributor-mediated acquisition for broader access, and dual sourcing for cost management and supply security.
Regional Dynamics: Americas prioritize governance and risk controls, EMEA places emphasis on sustainability and stringent oversight, while Asia-Pacific focuses on scaling capacity and meeting global export standards.
Core Technologies: Adoption of controlled fermentation, advanced impurity profiling, and robust process analytics, together with quality management frameworks, supports batch consistency and documentation for regulatory scrutiny.

Echinocandin B: Key Takeaways for Leadership

The value of Echinocandin B derives from its role as both a critical intermediate and a benchmark for quality in antifungal drug development. Robust manufacturing controls and a sophisticated documentation approach are central to product integrity.
Leading organizations are transitioning from dependence on a single supplier to qualifying multiple regions, prioritizing diversified procurement to enhance operational sustainability and minimize disruption risk.
Gaining and maintaining a competitive advantage is increasingly defined by excellence in process analytics, robust deviation management, and prioritization of supplier transparency in both documentation and monthly reporting cycles.
Geographic procurement behaviors emphasize different values, such as EMEA's focus on sustainability, the Americas' attention to regulatory alignment, and Asia-Pacific’s efficiency in scale-up. Supplier selection strategies reflect these nuances.
End users are creating segmented supply chains, sourcing from specialized partners for basic research versus regulated production programs to customize responses to audit and regulatory requirements, as well as ensure on-time project progression.

Tariff Impact: Navigating Policy and Supply Chain Complexity

Recent US tariff action is shifting supply chain and procurement behavior in the Echinocandin B market. While the active ingredient may not incur direct tariffs, adjacent cost components—such as reagents and packaging—are exposed to increased price volatility and potential delivery delays. This has prompted organizations to qualify additional manufacturing sites, augment safety stocks, and implement dynamic contract terms to buffer against disruptions. As a result, procurement and quality assurance teams are jointly prioritizing supplier documentation transparency and expedited document cycles to counteract evolving tariff exposure and related risks.

Methodology & Data Sources

The insights in this report are grounded in comprehensive desk research, direct engagement with industry stakeholders, and expert benchmarking. Analyses incorporate triangulated data from multi-region sourcing practices, supply chain audits, and quality management assessments to ensure actionable relevance for decision-making.

Echinocandin B Market: Why This Report Matters

Provides actionable clarity on how evolving clinical quality standards and regional procurement trends are shaping sourcing risk profiles for Echinocandin B.
Supports strategy development by showing how nuanced procurement approaches and application needs impact supplier selection, supply continuity, and compliance priorities.
Empowers procurement and quality teams to strengthen risk mitigation and quality assurance planning in response to ongoing regulatory, tariff, and supply chain pressures.

Conclusion

Success in the Echinocandin B market requires disciplined oversight of suppliers, strong sourcing frameworks, and responsiveness to shifting regulatory and documentation needs. Applying these findings enables organizations to build resilient, compliant antifungal development pipelines aligned with strategic and operational objectives.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Echinocandin B Market, by Product Type

8.1. Active Pharmaceutical Ingredient (API)
8.1.1. Crude Echinocandin B
8.1.2. Purified Echinocandin B
8.2. Intermediate For Derivatives
8.2.1. Caspofungin Intermediate
8.2.2. Micafungin Intermediate
8.2.3. Anidulafungin Intermediate
8.3. Finished Dosage Form
8.3.1. Injectable Formulations
8.3.2. Oral Formulations
8.4. Reference Standard
8.5. Custom Synthesis

9. Echinocandin B Market, by Route Of Administration

9.1. Intravenous
9.1.1. Continuous Infusion
9.1.2. Intermittent Infusion

10. Echinocandin B Market, by Formulation

10.1. Lyophilized Powder
10.1.1. Manual Reconstitution
10.1.2. Ready To Reconstitute
10.2. Prefilled Syringe

11. Echinocandin B Market, by Dosage Regimen

11.1. Once Daily
11.1.1. High Dose
11.1.2. Standard Dose
11.2. Twice Daily
11.2.1. High Dose
11.2.2. Standard Dose

12. Echinocandin B Market, by Packaging

12.1. Multi Dose Packaging
12.2. Single Dose Packaging

13. Echinocandin B Market, by Distribution Channel

13.1. Hospital Pharmacy
13.1.1. Direct Tender
13.1.2. Third Party Tender
13.2. Online Pharmacy
13.3. Retail Pharmacy

14. Echinocandin B Market, by Application

14.1. Therapeutic Development
14.1.1. Antifungal Drug Development
14.1.2. Combination Therapy Development
14.2. Commercial Production
14.2.1. Bulk Drug Manufacturing
14.2.2. Formulation Manufacturing
14.3. Research & Development
14.3.1. Mechanistic Studies
14.3.2. Resistance Profiling
14.3.3. Pharmacokinetic Studies
14.3.4. Toxicology Studies
14.4. Quality Control & Analytics
14.4.1. Reference Standards
14.4.2. Assay Calibration
14.4.3. Stability Testing
14.5. Diagnostic Use
14.5.1. Fungal Susceptibility Testing
14.5.2. Biomarker Assay Development

15. Echinocandin B Market, by End User

15.1. Pharmaceutical & Biotechnology Companies
15.1.1. Branded Drug Manufacturers
15.1.2. Generic Drug Manufacturers
15.1.3. Contract Manufacturing Organizations
15.2. Contract Research Organizations
15.3. Academic & Research Institutes
15.4. Diagnostic Laboratories
15.5. Government & Nonprofit Research Bodies

16. Echinocandin B Market, by Region

16.1. Americas
16.1.1. North America
16.1.2. Latin America
16.2. Europe, Middle East & Africa
16.2.1. Europe
16.2.2. Middle East
16.2.3. Africa
16.3. Asia-Pacific

17. Echinocandin B Market, by Group

17.1. ASEAN
17.2. GCC
17.3. European Union
17.4. BRICS
17.5. G7
17.6. NATO

18. Echinocandin B Market, by Country

18.1. United States
18.2. Canada
18.3. Mexico
18.4. Brazil
18.5. United Kingdom
18.6. Germany
18.7. France
18.8. Russia
18.9. Italy
18.10. Spain
18.11. China
18.12. India
18.13. Japan
18.14. Australia
18.15. South Korea

19. United States Echinocandin B Market
20. China Echinocandin B Market

21. Competitive Landscape

21.1. Market Concentration Analysis, 2025
21.1.1. Concentration Ratio (CR)
21.1.2. Herfindahl Hirschman Index (HHI)
21.2. Recent Developments & Impact Analysis, 2025
21.3. Product Portfolio Analysis, 2025
21.4. Benchmarking Analysis, 2025
21.5. Amneal Pharmaceuticals, Inc.
21.6. Apotex Inc.
21.7. Astellas Pharma Inc.
21.8. Cipla Limited
21.9. Dr. Reddy’s Laboratories Ltd.
21.10. F. Hoffmann-La Roche Ltd.
21.11. Fresenius SE & Co. KGaA
21.12. Gilead Sciences, Inc.
21.13. GlaxoSmithKline plc
21.14. Glenmark Pharmaceuticals Ltd.
21.15. Hikma Pharmaceuticals PLC
21.16. Merck & Co., Inc.
21.17. Novartis AG
21.18. Pfizer Inc.
21.19. Sanofi
21.20. Sun Pharmaceutical Industries Ltd.
21.21. Teva Pharmaceutical Industries Ltd.
21.22. Viatris Inc.
21.23. Wockhardt Limited
21.24. Zydus Lifesciences Limited

List of Figures

FIGURE 1. GLOBAL ECHINOCANDIN B MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ECHINOCANDIN B MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ECHINOCANDIN B MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ECHINOCANDIN B MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ECHINOCANDIN B MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL ECHINOCANDIN B MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ECHINOCANDIN B MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 15. UNITED STATES ECHINOCANDIN B MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 16. CHINA ECHINOCANDIN B MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL ECHINOCANDIN B MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CRUDE ECHINOCANDIN B, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CRUDE ECHINOCANDIN B, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CRUDE ECHINOCANDIN B, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PURIFIED ECHINOCANDIN B, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PURIFIED ECHINOCANDIN B, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PURIFIED ECHINOCANDIN B, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INTERMEDIATE FOR DERIVATIVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INTERMEDIATE FOR DERIVATIVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INTERMEDIATE FOR DERIVATIVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INTERMEDIATE FOR DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN INTERMEDIATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN INTERMEDIATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN INTERMEDIATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN INTERMEDIATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN INTERMEDIATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN INTERMEDIATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN INTERMEDIATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN INTERMEDIATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN INTERMEDIATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ECHINOCANDIN B MARKET SIZE, BY FINISHED DOSAGE FORM, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ECHINOCANDIN B MARKET SIZE, BY FINISHED DOSAGE FORM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ECHINOCANDIN B MARKET SIZE, BY FINISHED DOSAGE FORM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ECHINOCANDIN B MARKET SIZE, BY FINISHED DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INJECTABLE FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INJECTABLE FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INJECTABLE FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ORAL FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ORAL FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ECHINOCANDIN B MARKET SIZE, BY REFERENCE STANDARD, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ECHINOCANDIN B MARKET SIZE, BY REFERENCE STANDARD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ECHINOCANDIN B MARKET SIZE, BY REFERENCE STANDARD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CUSTOM SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CUSTOM SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CUSTOM SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CONTINUOUS INFUSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CONTINUOUS INFUSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CONTINUOUS INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INTERMITTENT INFUSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INTERMITTENT INFUSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INTERMITTENT INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MANUAL RECONSTITUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MANUAL RECONSTITUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MANUAL RECONSTITUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ECHINOCANDIN B MARKET SIZE, BY READY TO RECONSTITUTE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ECHINOCANDIN B MARKET SIZE, BY READY TO RECONSTITUTE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ECHINOCANDIN B MARKET SIZE, BY READY TO RECONSTITUTE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PREFILLED SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PREFILLED SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HIGH DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HIGH DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HIGH DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ECHINOCANDIN B MARKET SIZE, BY STANDARD DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ECHINOCANDIN B MARKET SIZE, BY STANDARD DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ECHINOCANDIN B MARKET SIZE, BY STANDARD DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HIGH DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HIGH DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HIGH DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ECHINOCANDIN B MARKET SIZE, BY STANDARD DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ECHINOCANDIN B MARKET SIZE, BY STANDARD DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ECHINOCANDIN B MARKET SIZE, BY STANDARD DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MULTI DOSE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MULTI DOSE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MULTI DOSE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ECHINOCANDIN B MARKET SIZE, BY SINGLE DOSE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ECHINOCANDIN B MARKET SIZE, BY SINGLE DOSE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ECHINOCANDIN B MARKET SIZE, BY SINGLE DOSE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DIRECT TENDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DIRECT TENDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ECHINOCANDIN B MARKET SIZE, BY THIRD PARTY TENDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL ECHINOCANDIN B MARKET SIZE, BY THIRD PARTY TENDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ECHINOCANDIN B MARKET SIZE, BY THIRD PARTY TENDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ECHINOCANDIN B MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ECHINOCANDIN B MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL ECHINOCANDIN B MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL ECHINOCANDIN B MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL ECHINOCANDIN B MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL ECHINOCANDIN B MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL ECHINOCANDIN B MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ANTIFUNGAL DRUG DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ANTIFUNGAL DRUG DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ANTIFUNGAL DRUG DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL ECHINOCANDIN B MARKET SIZE, BY COMBINATION THERAPY DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL ECHINOCANDIN B MARKET SIZE, BY COMBINATION THERAPY DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL ECHINOCANDIN B MARKET SIZE, BY COMBINATION THERAPY DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL ECHINOCANDIN B MARKET SIZE, BY COMMERCIAL PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL ECHINOCANDIN B MARKET SIZE, BY COMMERCIAL PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL ECHINOCANDIN B MARKET SIZE, BY COMMERCIAL PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL ECHINOCANDIN B MARKET SIZE, BY COMMERCIAL PRODUCTION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL ECHINOCANDIN B MARKET SIZE, BY BULK DRUG MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL ECHINOCANDIN B MARKET SIZE, BY BULK DRUG MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL ECHINOCANDIN B MARKET SIZE, BY BULK DRUG MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL ECHINOCANDIN B MARKET SIZE, BY FORMULATION MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL ECHINOCANDIN B MARKET SIZE, BY FORMULATION MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL ECHINOCANDIN B MARKET SIZE, BY FORMULATION MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL ECHINOCANDIN B MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL ECHINOCANDIN B MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL ECHINOCANDIN B MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL ECHINOCANDIN B MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MECHANISTIC STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MECHANISTIC STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MECHANISTIC STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL ECHINOCANDIN B MARKET SIZE, BY RESISTANCE PROFILING, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL ECHINOCANDIN B MARKET SIZE, BY RESISTANCE PROFILING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL ECHINOCANDIN B MARKET SIZE, BY RESISTANCE PROFILING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL ECHINOCANDIN B MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL ECHINOCANDIN B MARKET SIZE, BY TOXICOLOGY STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL ECHINOCANDIN B MARKET SIZE, BY TOXICOLOGY STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL ECHINOCANDIN B MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL ECHINOCANDIN B MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL ECHINOCANDIN B MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL ECHINOCANDIN B MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL ECHINOCANDIN B MARKET SIZE, BY REFERENCE STANDARDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL ECHINOCANDIN B MARKET SIZE, BY REFERENCE STANDARDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL ECHINOCANDIN B MARKET SIZE, BY REFERENCE STANDARDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ASSAY CALIBRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ASSAY CALIBRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ASSAY CALIBRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL ECHINOCANDIN B MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL ECHINOCANDIN B MARKET SIZE, BY STABILITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL ECHINOCANDIN B MARKET SIZE, BY STABILITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DIAGNOSTIC USE, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DIAGNOSTIC USE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DIAGNOSTIC USE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DIAGNOSTIC USE, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL ECHINOCANDIN B MARKET SIZE, BY FUNGAL SUSCEPTIBILITY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL ECHINOCANDIN B MARKET SIZE, BY FUNGAL SUSCEPTIBILITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL ECHINOCANDIN B MARKET SIZE, BY FUNGAL SUSCEPTIBILITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL ECHINOCANDIN B MARKET SIZE, BY BIOMARKER ASSAY DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL ECHINOCANDIN B MARKET SIZE, BY BIOMARKER ASSAY DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL ECHINOCANDIN B MARKET SIZE, BY BIOMARKER ASSAY DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL ECHINOCANDIN B MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL ECHINOCANDIN B MARKET SIZE, BY BRANDED DRUG MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL ECHINOCANDIN B MARKET SIZE, BY BRANDED DRUG MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL ECHINOCANDIN B MARKET SIZE, BY BRANDED DRUG MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL ECHINOCANDIN B MARKET SIZE, BY GENERIC DRUG MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL ECHINOCANDIN B MARKET SIZE, BY GENERIC DRUG MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL ECHINOCANDIN B MARKET SIZE, BY GENERIC DRUG MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL ECHINOCANDIN B MARKET SIZE, BY GOVERNMENT & NONPROFIT RESEARCH BODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL ECHINOCANDIN B MARKET SIZE, BY GOVERNMENT & NONPROFIT RESEARCH BODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL ECHINOCANDIN B MARKET SIZE, BY GOVERNMENT & NONPROFIT RESEARCH BODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL ECHINOCANDIN B MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 199. AMERICAS ECHINOCANDIN B MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 200. AMERICAS ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 201. AMERICAS ECHINOCANDIN B MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), 2018-2032 (USD MILLION)
TABLE 202. AMERICAS ECHINOCANDIN B MARKET SIZE, BY INTERMEDIATE FOR DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 203. AMERICAS ECHINOCANDIN B MARKET SIZE, BY FINISHED DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 204. AMERICAS ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 205. AMERICAS ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 206. AMERICAS ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 207. AMERICAS ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
TABLE 208. AMERICAS ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 209. AMERICAS ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2018-2032 (USD MILLION)
TABLE 210. AMERICAS ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2018-2032 (USD MILLION)
TABLE 211. AMERICAS ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 212. AMERICAS ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 213. AMERICAS ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 214. AMERICAS ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. AMERICAS ECHINOCANDIN B MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 216. AMERICAS ECHINOCANDIN B MARKET SIZE, BY COMMERCIAL PRODUCTION, 2018-2032 (USD MILLION)
TABLE 217. AMERICAS ECHINOCANDIN B MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 218. AMERICAS ECHINOCANDIN B MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, 2018-2032 (USD MILLION)
TABLE 219. AMERICAS ECHINOCANDIN B MARKET SIZE, BY DIAGNOSTIC USE, 2018-2032 (USD MILLION)
TABLE 220. AMERICAS ECHINOCANDIN B MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. AMERICAS ECHINOCANDIN B MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 222. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 224. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), 2018-2032 (USD MILLION)
TABLE 225. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY INTERMEDIATE FOR DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 226. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY FINISHED DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 227. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 228. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 229. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 230. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
TABLE 231. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 232. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2018-2032 (USD MILLION)
TABLE 233. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2018-2032 (USD MILLION)
TABLE 234. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 235. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 236. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 237. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 238. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 239. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY COMMERCIAL PRODUCTION, 2018-2032 (USD MILLION)
TABLE 240. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 241. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, 2018-2032 (USD MILLION)
TABLE 242. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY DIAGNOSTIC USE, 2018-2032 (USD MILLION)
TABLE 243. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 244. NORTH AMERICA ECHINOCANDIN B MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 245. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 246. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 247. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), 2018-2032 (USD MILLION)
TABLE 248. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY INTERMEDIATE FOR DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 249. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY FINISHED DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 250. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 251. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 252. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 253. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
TABLE 254. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 255. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2018-2032 (USD MILLION)
TABLE 256. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2018-2032 (USD MILLION)
TABLE 257. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 258. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 259. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 260. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 261. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 262. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY COMMERCIAL PRODUCTION, 2018-2032 (USD MILLION)
TABLE 263. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 264. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, 2018-2032 (USD MILLION)
TABLE 265. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY DIAGNOSTIC USE, 2018-2032 (USD MILLION)
TABLE 266. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 267. LATIN AMERICA ECHINOCANDIN B MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), 2018-2032 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY INTERMEDIATE FOR DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY FINISHED DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2018-2032 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2018-2032 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY COMMERCIAL PRODUCTION, 2018-2032 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, 2018-2032 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY DIAGNOSTIC USE, 2018-2032 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 291. EUROPE ECHINOCANDIN B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 292. EUROPE ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 293. EUROPE ECHINOCANDIN B MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), 2018-2032 (USD MILLION)
TABLE 294. EUROPE ECHINOCANDIN B MARKET SIZE, BY INTERMEDIATE FOR DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 295. EUROPE ECHINOCANDIN B MARKET SIZE, BY FINISHED DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 296. EUROPE ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 297. EUROPE ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 298. EUROPE ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 299. EUROPE ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
TABLE 300. EUROPE ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 301. EUROPE ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2018-2032 (USD MILLION)
TABLE 302. EUROPE ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2018-2032 (USD MILLION)
TABLE 303. EUROPE ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 304. EUROPE ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 305. EUROPE ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 306. EUROPE ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 307. EUROPE ECHINOCANDIN B MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 308. EUROPE ECHINOCANDIN B MARKET SIZE, BY COMMERCIAL PRODUCTION, 2018-2032 (USD MILLION)
TABLE 309. EUROPE ECHINOCANDIN B MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 310. EUROPE ECHINOCANDIN B MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, 2018-2032 (USD MILLION)
TABLE 311. EUROPE ECHINOCANDIN B MARKET SIZE, BY DIAGNOSTIC USE, 2018-2032 (USD MILLION)
TABLE 312. EUROPE ECHINOCANDIN B MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 313. EUROPE ECHINOCANDIN B MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 314. MIDDLE EAST ECHINOCANDIN B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 315. MIDDLE EAST ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 316. MIDDLE EAST ECHINOCANDIN B MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), 2018-2032 (USD MILLION)
TABLE 317. MIDDLE EAST ECHINOCANDIN B MARKET SIZE, BY INTERMEDIATE FOR DERIVATIVES, 2018-2032 (USD MILLIO

Companies Mentioned

The key companies profiled in this Echinocandin B market report include:

Amneal Pharmaceuticals, Inc.
Apotex Inc.
Astellas Pharma Inc.
Cipla Limited
Dr. Reddy’s Laboratories Ltd.
F. Hoffmann-La Roche Ltd.
Fresenius SE & Co. KGaA
Gilead Sciences, Inc.
GlaxoSmithKline plc
Glenmark Pharmaceuticals Ltd.
Hikma Pharmaceuticals PLC
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Wockhardt Limited
Zydus Lifesciences Limited

Table Information

Report Attribute	Details
No. of Pages	184
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 305.95 Million
Forecasted Market Value ( USD ) by 2032	$ 612.34 Million
Compound Annual Growth Rate	12.5%
Regions Covered	Global
No. of Companies Mentioned	21

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3513EUR$3,939USD£3,047GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3789EUR$4,249USD£3,286GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5136EUR$5,759USD£4,454GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6215EUR$6,969USD£5,390GBP

Market Snapshot: Echinocandin B Market Size and Trajectory

Scope & Segmentation: Diverse Applications and Strategic Suppliers

Echinocandin B: Key Takeaways for Leadership

Tariff Impact: Navigating Policy and Supply Chain Complexity

Methodology & Data Sources

Echinocandin B Market: Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Reports

Aspergillosis Treatment Drug Market - Global Forecast 2025-2030

Cryptococcosis Market - Global Forecast 2026-2032

Echinocandin B Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

AntiFungal Drugs Market Overview, 2025-2030

Antifungal Drugs - Global Strategic Business Report